We are very pleased to report that our latest paper, “A Systematic Review and Meta-Analysis of the Effect of Intraoperative Bupivacaine in Gynaecologic Surgery After 24 Hours or 9 Half-lives” has been published in the prestigious Journal of Obstetrics and Gynecology of Canada, and also appears online in the US government’s “Pubmed” website. We look…
The Marchand Institute for Minimally Invasive Surgery is very grateful to the Journal of Minimally Invasive Gynecologic Surgery (JMIG), The American Association of Gynecologic Laparoscopists (AAGL), and Dr. Peter Movilla for featuring our work on Laparoscopic Cerclage in their latest Podcast! You can listen to the full Podcast on Itunes at this link: https://podcasts.apple.com/us/podcast/migs-front-page-the-official-jmig-podcast/id1526164934 As…
Although drug and surgical device patents are extremely common in the United States, actually patenting a surgical procedure is quite rare. This is largely because Federal Law prohibits any enforcement of patent infringement on surgical procedures under 35 U.S.C. § 287(c). Dr. Gregory Marchand received final approval this month of a very rare type of…
To compliment our already existing fellowship program, as well as enhance our surgical research and compliment our educational programs for medical students and residents, we are very excited to announce the completion of our Simulation Laboratory. This is the most advanced Surgical Simulation Laboratory in the USA incorporating both advanced laparoscopic and robotic simulators. Although…
Dr. Marchand is very excited to announce that his new Surgical Technique, “The Marchand Salpingectomy – A Five Minute Procedure That Decreases the Risk of Ovarian Cancer for a Lifetime,” has been accepted for Presentation at the Annual American College of Surgeon’s Conference. The Video and Multimedia presentation will be given on Tuesday, October 24, 2017 in…